Skip to main content

Table 1 Summary of M. tuberculosis susceptibility profile test based on Genotype MTBDRplus compared to gender, HIV co-infection and previous use of first line drugs against tuberculosis

From: Drug-resistant tuberculosis in Central Mozambique: the role of a rapid genotypic susceptibility testing

  Gender HIV Previous treatment of TB Total
M. tb status M F Unk p value Pos Neg Unk p value Yes No Unk p value
Susceptible 55 71.4 % 49 79.0 % 11 (68.7) 0,33 29 66.0 % 20 71.4 % 66 79.6 % 0,80 73 72.2 % 33 80.5 % 9 69.2 % 0,02 115 74.2 %
MDR-TB 12 15.6 % 10 16.2 % 3 (18.8) 11 25.0 % 5 17.9 % 9 (10.8) 20 19.8 % 4 9.8 % 1 7.7 % 25 16.1 %
R-mono resistant 2 2.6 % 0 0 (0.0) 1 2.2 % 0 1 1.2 % 1 1.0 % 1 2.4 % 0 2 1.3 %
H-mono resistant 8 10.4 % 3 4.8 % 2 (12.5) 3 6.8 % 3 10.7 % 7 8.4 % 7 7.0 % 3 7.3 % 3 23.1 % 13 8.4 %
Total 77 62 16   44 28 83   101 41 13   155 100 %
  1. M. tb Mycobacterium tuberculosis, M male, F female, Unk unknown, Pos positive, Neg negative, MDR-TB isolates resistant to rifampicin and isoniazid, R-mono resistant only to rifampicin, H-mono resistant only to isoniazid
  2. Chi-square and Fisher comparing susceptible and non-susceptible groups. Significance p < 0.05